The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.
Browse all articles A–Z →
Amifampridine (Firdapse) Shortage: What Providers and Prescribers Need to Know in 2026
Amifampridine (Firdapse) isn't in shortage, but specialty access barriers create real challenges for LEMS patients. Here's what prescribers need to know to help patients access it in 2026.

Analpram HC Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for providers on Analpram HC availability in 2026: formulary status, prescribing alternatives, and how to help patients navigate pharmacy stockouts.

Anusol HC Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for providers on Anusol HC availability, therapeutic substitutes, and how to help patients navigate prescription filling challenges in 2026.

Apidra Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing on Apidra (insulin glulisine) supply and availability in 2026 — what prescribers need to know about stock gaps, alternatives, and patient resources.
48,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.

Arazlo Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for dermatologists and prescribers on Arazlo availability in 2026 — covering supply gaps, prescribing considerations, and patient access tools.

Arimidex Shortage: What Providers and Prescribers Need to Know in 2026
Clinicians managing breast cancer patients on anastrozole need current information on availability, clinical alternatives, and patient communication strategies for 2026.

Atogepant Shortage: What Providers and Prescribers Need to Know in 2026
A 2026 clinical guide for providers on atogepant (Qulipta) availability, PA requirements, formulary barriers, and patient access strategies.

Bactroban Shortage: What Providers and Prescribers Need to Know in 2026
No active FDA shortage exists for Bactroban in 2026, but providers should understand local availability gaps, resistance trends, and when to switch.

Besivance Availability: What Providers and Prescribers Need to Know in 2026
A clinical briefing for ophthalmologists, optometrists, and prescribers on Besivance (besifloxacin) availability, insurance barriers, and alternative management strategies in 2026.

Betamethasone Shortage: What Providers and Prescribers Need to Know in 2026
Betamethasone is not in a national shortage, but providers are seeing access issues linked to formulation fragmentation and spill-over demand. Here's the clinical picture for 2026.

Bethanechol Shortage: What Providers and Prescribers Need to Know in 2026
A clinical brief for urologists, PCPs, and other prescribers on bethanechol availability in 2026 — current supply status, patient counseling tips, and alternatives.

Brenzavvy (Bexagliflozin) Shortage: What Providers and Prescribers Need to Know in 2026
Brenzavvy (bexagliflozin) is clinically effective and highly affordable — but its distribution model creates prescription access challenges. Here's what prescribers need to know in 2026.